Andrew David Norden MD, MPH, MBA

Dr. Norden received his medical degree from Yale University School of Medicine in 2002. He subsequently completed his residency in Neurology at Brigham and Women's and Massachusetts General Hospitals. He also completed a Neuro-Oncology fellowship at Dana-Farber Cancer Institute and Massachusetts General Hospital. He is an attending physician in the Neuro-Oncology Clinic at Dana-Farber Cancer Institute and in Neurology at Brigham and Women's Hospital. His research is focused on clinical trials of novel chemotherapy agents for malignant gliomas and other primary brain tumors